Article: Clonetics Corp. announces the development of the first commercial research product using laboratory-grown skin cells.

BOULDER, Colo., Nov. 3 /PRNewswire/ -- The development of the first commercial research product using laboratory-grown skin cells was announced today by Clonetics Corporation, a privately held, Boulder based research and development company.

The EpiPack(TM), which provides normal human epidermal keratinocyte (skin cells) and all the ingredients necessary for their growth in a unique serum-free medium (KGM), enables researchers to screen, quickly and economically, the reaction of human skin cells to chemical and environmental substances, biomedical materials and medical implant devices.

"Industry, government and academic researchers are now able to ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!